CSPAM
NVS icon

Cary Street Partners Asset Management’s Novartis NVS Stock Holding History

Cary Street Partners Asset Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$551K Sell
4,787
-576
-11% -$65.4K 0.07% 143
2024
Q2 		$571K Sell
5,363
-142
-3% -$14.3K 0.08% 140
2024
Q1 		$533K Hold
5,505
– – 0.08% 140
2023
Q4 		$556K Sell
5,505
-88
-2% -$8.49K 0.1% 132
2023
Q3 		$570K Sell
5,593
-137
-2% -$13.9K 0.11% 131
2023
Q2 		$578K Sell
5,730
-725
-11% -$72.5K 0.11% 133
2023
Q1 		$594K Sell
6,455
-800
-11% -$69.9K 0.11% 120
2022
Q4 		$658K Sell
7,255
-104
-1% -$8.76K 0.13% 119
2022
Q3 		$559K Buy
7,359
+4
+0.1% +$332 0.13% 111
2022
Q2 		$622K Sell
7,355
-6,173
-46% -$542K 0.15% 113
2022
Q1 		$1.19M Buy
13,528
+100
+0.7% +$8.66K 0.24% 94
2021
Q4 		$1.18M Sell
13,428
-2,628
-16% -$218K 0.25% 98
2021
Q3 		$1.31M Sell
16,056
-1,171
-7% -$105K 0.46% 71
2021
Q2 		$1.57M Sell
17,227
-102,211
-86% -$9.1M 0.38% 76
2021
Q1 		$1.68M Sell
119,438
-38,237
-24% -$3.43M 0.41% 73
2020
Q4 		$4.96M Buy
+157,675
New +$13.8M 1.47% 14

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Cary Street Partners Asset Management's NVS Position: Q3 2024 in Review

Cary Street Partners Asset Management reduced its Novartis (NVS) stake by 11% in Q3 2024, selling an estimated $65.4K and leaving 4,787 shares worth $551K. The position accounts for 0.07% of the portfolio, ranked #143.

Cary Street Partners Asset Management first reported a position in NVS in Q4 2020 and has held it in 16 quarters since. The position peaked at $4.96M in Q4 2020. 1,312 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • Cary Street Partners Asset Management held 4,787 shares of Novartis worth $551K as of Q3 2024.
  • Cary Street Partners Asset Management sold 576 Novartis shares in Q3 2024, an estimated $65.4K.
  • Novartis made up 0.07% of Cary Street Partners Asset Management's portfolio in Q3 2024, its #143 holding.
  • Cary Street Partners Asset Management first reported a position in Novartis in Q4 2020 and has held it in 16 quarters since.
  • Cary Street Partners Asset Management's Novartis position peaked at $4.96M in Q4 2020.
  • 1,312 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Cary Street Partners Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.